Study reveals 45% drop in oxycodone use in Australia after policy changes

Between 2018 and 2020, Australia implemented policy changes to improve the quality and safety of opioid prescribing, with a specific focus on oxycodone.

Rucaparib camsylate by Pharmaand for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

May 20, 2024

Treatment of Oligometastatic EGFR-Mutant Lung Cancer

EGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, even after undergoing systemic therapy, patients may have oligometastatic

November 23, 2024

How Cardiac Arrest Became a Household Topic After Damar Hamlin’s Collapse

In January, we reported on Damar Hamlin’s collapse during a televised football game. In this report, we follow up on the resulting public interest on

January 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.